| Name | Title | Contact Details |
|---|
Southtowns Radiology is a medical imaging and diagnostic radiology center with offices in Hamburg and Orchard Park, providing state-of-the-art imaging, screening, and diagnostic services with a patient-centered approach to care.
Micro Invasive Technology is a Pomfret Center, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
National Home Health Care Corp., through its five subsidiaries, delivers the highest quality of homecare to address the practical, physical and emotional needs of its patients and their families.
North American Dental Group is a premier dental group with a commitment to industry-leading service and care for EVERY PATIENT, EVERY VISIT. We have a true partnership with our affiliated dentists enabling them to focus on what they do best and love most… dentistry. With our patient-centric approach, our mission is to serve our doctors and their clinical support teams so they have clinical autonomy to provide the very best treatment focused on EMPATHY, COMPASSION and CARE. We provide comprehensive support to 260+ dental practices with the understanding that it requires the efforts of everyone to achieve our goals for patient care.
Our name, Monogram, symbolizes the personalized focus of our services. While the application of the latest technology and data science is critical to our success, we never lose sight that healthcare is ultimately about trusted individual relationships between healthcare professionals and their patients. Unfortunately, individuals living with advanced CKD and ESRD are negatively impacted by well entrenched systematic forces such as perverse economic incentives, poor adherence to evidence-based care, and a lack of sensitivity to the negative impacts of social determinants of health. The 21st Century Cures Act is a seminal piece of legislation designed to shift individuals living with ESRD from FFS Medicare into managed care and reverse decades and decades of sub-optimal outcomes. Monogram was born with a vision to serve health plans and other sponsors of health care and solve for these systemic problems. Our mission is to improve clinical outcomes by predicting the onset of CKD and ESRD, slowing its progression, and reducing hospitalizations, morbidity and mortality. We are founded and operated by a core group of former government programs health plan executives, including our CEO, Michael Uchrin, a world-renown nephrologist and author of over 200 published pieces of research, Dr. Raymond Hakim, and former US Senator Bill Frist M.D., a retired cardiac surgeon and recognized leader for improving the quality of care provided to human beings across the world. We welcome all stakeholders in the CKD | ESRD ecosystem to join us in our mission to measurably improve outcomes for individuals living with these conditions.